Welcome to LookChem.com Sign In|Join Free
  • or
1-[(3S,1R)-3-N-BOC-aminocyclopentyl]-1-ethanone is a cyclopentylamine derivative with the chemical formula C13H23NO3. It features a specific arrangement of atoms, with the "BOC" group indicating the presence of a tert-butyloxycarbonyl protective group for amines. 1-[(3S,1R)-3-N-BOC-aminocyclopentyl]-1-ethanone is significant in the development of new drugs and bioactive compounds, serving as a valuable building block in organic chemistry research.

204913-01-9

Post Buying Request

204913-01-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

204913-01-9 Usage

Uses

Used in Pharmaceutical Synthesis:
1-[(3S,1R)-3-N-BOC-aminocyclopentyl]-1-ethanone is used as an intermediate in the synthesis of pharmaceuticals for its ability to protect amines from unwanted reactions during the drug development process.
Used in Organic Chemistry Research:
In the field of organic chemistry, 1-[(3S,1R)-3-N-BOC-aminocyclopentyl]-1-ethanone is utilized as a building block for the creation of various organic compounds, contributing to the advancement of chemical knowledge and the development of novel substances.

Check Digit Verification of cas no

The CAS Registry Mumber 204913-01-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,9,1 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 204913-01:
(8*2)+(7*0)+(6*4)+(5*9)+(4*1)+(3*3)+(2*0)+(1*1)=99
99 % 10 = 9
So 204913-01-9 is a valid CAS Registry Number.

204913-01-9Upstream product

204913-01-9Relevant academic research and scientific papers

1,3,4-OXADIAZOLONE COMPOUND AND MEDICINE

-

Paragraph 0336; 0479; 0480, (2021/09/24)

The purpose of the present invention is to provide a compound having PIM inhibitory activity. Examples of the present invention include 1,3,4-oxadiazolone compounds represented by the following formula [1], and pharmaceutically acceptable salts, and solvates thereof. The compounds of the present invention have PIM inhibitory activity. In addition, since the compounds of the present invention have PIM inhibitory activity, the compounds of the present invention are useful as therapeutic agents for systemic lupus erythematosus, lupus nephritis, etc.

DIPEPTIDYL PEPTIDASE IV INHIBITOR COMPOUNDS AND COMPOSITIONS

-

Page/Page column 25, (2010/11/28)

The present invention relates to dipeptidyl peptidase IV (DPP-IV) inhibitors of formula (1), pharmaceutical compositions containing them, processes for their preparation, and methods for treating disorders mediated by DPP-IV inhibition, such as diabetes, especially Type II diabetes, with them, wherein Rj is substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroarylalkyl, substituted or unsubstituted heterocyclic ring, substituted or unsubstituted heterocyclylalkyl; R2 is hydrogen or Q-β alkyl; Y is -S(O)m, -CH2-, -CHF or CF2; R3 is hydrogen, nitrile (-CN), COOH, or an isostere of a carboxylic acid.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 204913-01-9